An AICD-based functional screen to identify APP metabolism regulators
2007

Identifying Regulators of APP Metabolism in Alzheimer's Disease

publication Evidence: high

Author Information

Author(s): Zhang Can, Khandelwal Preeti J, Chakraborty Ranjita, Cuellar Trinna L, Sarangi Srikant, Patel Shyam A, Cosentino Christopher P, O'Connor Michael, Lee Jeremy C, Tanzi Rudolph E, Saunders Aleister J

Primary Institution: Drexel University

Hypothesis

Can we develop a genetic screen to identify regulators of APP metabolism using an AICD-based functional assay?

Conclusion

The study demonstrates that Ubiquilin 1 regulates APP metabolism and can be identified as a regulator using the AICD-Gal4 mediated luciferase assay.

Supporting Evidence

  • The AICD-Gal4 mediated luciferase assay accurately reflects changes in APP metabolism.
  • Ubiquilin 1 was shown to modulate APP levels and PS1 endoproteolysis.
  • Pharmacologic modulation of secretase activities resulted in predictable changes in luciferase activity.

Takeaway

Researchers created a test to find out how certain proteins affect the processing of a protein linked to Alzheimer's disease, and they found that Ubiquilin 1 plays an important role.

Methodology

The study used an AICD-Gal4 mediated luciferase assay in SH-SY5Y neuroblastoma cells to identify regulators of APP metabolism through pharmacologic and genetic manipulation.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1186/1750-1326-2-15

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication